Lipids Update 2022: Cardiovascular Risk Reduction and New Medications on the Horizon with Erin Michos, MD

Show description:
Ready to take the next step in management of your patient with hyperlipidemia? Dr. Erin Michos (@erinmichos) returns to give us a lesson in Advanced Lipidology. She updates us on what new medications we can use for those difficult to treat lipids and what medications are on the horizon.

Unfortunately, this episode will not be available for CME. You can claim free CME for other episodes at curbsiders.vcuhealth.org!

Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | askcurbsiders@gmail.com | Free CME!

Show Segments

Intro, Getting to know Dr. Erin Michos, Pick of the Week
Patient Case, Digging into ASCVD Risk
Coronary artery calcium scoring - why it’s important
What are “Risk Enhancing Factors”?
Biomarker testing, what is the significance of Lip a and how can we use it to drive management?
Introduction to PCSK9 inhibitors
More than just statins - other LDL-lowering medications
siRNAs, ASOs - Pelacarsen and more
Apollo Trial regarding Pelacarsen
Importance of Family History
What to do if maxed out on a statin or statin intolerance - Ezetimibe, PCSK9 inhibitors, MAB therapies, and more
Bempedoic Acid discussion
Medication side effects
Homozygous FH - approach to treatment, ANGPTL3 inhibitors
Triglycerides discussion, icosapent ethyl, the REDUCE-IT trial
Wrap-up and Take home points, Outtro

Credits

Producer and written by: Christopher Chiu MD, FACP, FAAP
Show Notes: James Antaki MD
Infographic: Edison Jyang
Cover Art: Kate Grant MBChB, DipGUMed
Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
Associate Editor: Leah Witt MD
Showrunner: Matthew Watto MD, FACP
Technical Production: PodPaste
Guest: Erin Michos MD, MHS

Sponsor: Birch Living

Birch is giving $400 off all mattresses and 2 free eco-rest pillows at BirchLiving.com/curb.

Full transcript HERE

#230 Irony, sarcasm, and cynicism. Differences.

#230  Irony, sarcasm, and cynicism. Differences.